Multicenter Cohort Study of AAV in Hunan of China
Recruiting · NCT05315141 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
No Intervention
What this trial is about
This study aimed to explore the incidence of Anti-neutrophil cytoplasmic antibody (ANCA）-associated vasculitis (AAV) progression and its association with adverse consequences. It will enroll approximately 500 AAV patients in Hunan province of China and follow-up for at least 5 years. Demographic characteristics, clinical and laboratory data will be collected at baseline and every follow-up. The principal clinical outcomes of the study consist of end stage renal disease (ESRD) and death.
Who can take part
Age range
No age limits stated
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Fulfill 2012 criteria of ANCA associated vasculitis and agree to sign informed consent
Exclusion criteria
- Do not agree to sign informed consent
Where it is running
1 location listed.
- Xiangya hospital - Changsha, Hunan, China